세계의 정맥주사액 시장 : 용액별, 가방 유형별, 용도별, 최종 사용자별, 지역별 시장 규모, 점유율, 전망, 기회 분석(2025-2032년)
Intravenous Solutions Market, by Solution, by Bag Type, by Application, by End User, and by Region Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
상품코드
:
1705645
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 정맥주사액 시장은 2025년 110억 5,000만 달러로 추정되고, 2032년까지 169억 5,000만 달러에 이를 것으로 예측되고, 2025년부터 2032년까지 연평균 성장률(CAGR) 6.3%를 보일 것으로 예측됩니다.
| 보고 범위 |
보고서 세부정보 |
| 기준연도 |
2024년 |
2025년 시장 규모 |
110억 5,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간: 2025-2032년 CAGR: |
6.30% |
2032년 가치 예측 |
169억 5,000만 달러 |
그림. 정맥주사액 시장 점유율(%), 2025년 지역별
정맥내 솔루션은 정맥 순환에 직접 투여되는 체액입니다. 이 주입은 멸균 비 파이로젠 솔루션, 정맥 내 투여를 위한 단일 용량 용기에 넣어 수분 및 칼로리 보급에 사용됩니다. 염화나트륨, 젖산 링거, 수중 포도당 등 시장에서 이용 가능한 정맥주사액에는 여러 유형이 있습니다. 점적 요법은 영양 부족이나 탈수로 고통받는 환자에게 이상적입니다. 탈수는 다음과 같은 다양한 영향을 유발할 수 있습니다.
- 신체의 중요한 미네랄(전해질) 균형
- 인지(정신) 능력
- 에너지 레벨
- 위장 기능(음식을 소화하고 대소변을 만드는 능력)
- 두통의 빈도와 강도
- 신체 능력
- 피부 건강 상태
시장 역학
설사증의 유병률 증가는 예측 기간 동안 세계 정맥주사액 시장의 성장을 밀어올릴 것으로 예측됩니다. 예를 들어, 2022년 7월, 세계 어린이들에게 인도적 및 개발적 원조를 제공하는 유엔의 기관인 UNICEF(UN 국제 아동 긴급 기금)는 설사에 의한 2020년 세계의 5세 미만 아동의 전체 사망의 9%를 차지하는 한편, 설사에 의해 매일 1,300명 이상의 유아가 사망해, 세계 전체에서 연간 약 48만 4,000명의 아이가 사망하고 있다고 하는 보고서를 발표했습니다.
게다가 2018년 9월 Lancet Infectious Diseases에 게재된 논문에 따르면 설사는 2016년 장애조정 생존년(DALYs)의 제3위의 원인이며, 전 세계적으로 7,440만 DALYs를 차지하고 있습니다. 이 출처에 따르면 설사는 사망 원인 중 8위였으며, 2016년 사망자 수는 전 세계적으로 165만 5,944명이었습니다.
본 조사의 주요 특징
- 본 보고서에서는 세계 정맥주사액 시장에 대해 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모를 상세하게 분석했습니다.
- 다양한 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 기업 개요, 재무 실적, 제품 포트폴리오, 지리적 존재, 유통 전략, 주요 발전, 전략 등의 파라미터를 바탕으로 세계의 점적 솔루션 시장의 주요 기업 프로파일을 제공합니다.
- 본 보고서의 인사이트에 의해 기업의 마케팅 담당자나 경영진은 장래의 제품 발매, 정부의 대처, 기술 향상, 시장 확대, 마케팅 전술에 관해서, 정보에 근거한 의사 결정을 실시할 수 있습니다.
- 이 조사 보고서는 투자자, 제품 제조업체, 유통업체, 이해관계자, 리서치사, 컨설팅 회사, 신규 참가기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 하고 있습니다.
- 이해관계자는 세계의 정맥주사액 시장의 분석에 사용되는 다양한 전략 매트릭스를 통해, 의사 결정을 용이하게 할 수 있습니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 시장 동향
- 주요 발전
- 역학
- Porter's Five Forces 분석
제4장 세계의 정맥주사액 시장 - 코로나 바이러스(COVID-19) 팬데믹의 영향
- 전체적인 영향
- COVID-19에 의한 시장에 대한 영향
제5장 세계의 정맥주사액 시장 : 용액별, 2020-2032년
- 생리 식염수
- 생리 식염수(0.9% NaCl)
- 고장 식염수
- 덱스트란
- 젖산 링거액
- 아미노산
- 비타민 및 미네랄
- 헤파린 및 미량 원소
- 혼합 솔루션
제6장 세계의 정맥주사액 시장 : 가방 유형별, 2020-2032년
- 대용량 가방(250ml 이상)
- 소용량 가방(250ml 미만)
제7장 세계의 정맥주사액 시장 : 용도별, 2020-2032년
- 기본 IV 용액
- 영양 IV 용액
- 혈액 IV 용액
- 약제 IV 용액
- 관개 IV 용액
제8장 세계의 정맥주사액 시장 : 최종 사용자별, 2020-2032년
- 병원
- 클리닉
- 외래수술센터(ASC)
- 가정치료 환경
제9장 세계의 정맥주사액 시장 : 지역별, 2020-2032년
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제10장 경쟁 구도
- 히트맵 분석
- 기업 프로파일
- Baxter International Inc.
- ICU Medical, Inc.
- B. Braun Melsungen Ag
- Grifols, SA
- Fresenius Kabi USA, LLC
- Vifor Pharma Management Ltd.
- JW Life Science
- Amanta Healthcare
- Axa Parenterals Ltd
- Salius Pharma Private Limited.
- Pfizer, Inc.
- Otsuka Pharmaceutical Co., Ltd
- Ajinomoto Co., Inc.
- Braun Melsungen AG
- Soxa Formulations & Research Pvt. Ltd
- Sichuan Kelun Pharmaceutical Co Ltd
제11장 분석가 추천
- 운명의 원
- 애널리스트의 견해
- 일관성 있는 기회 맵
제12장 섹션
JHS
영문 목차
Global Intravenous Solutions Market is estimated to be valued at USD 11.05 Bn in 2025 and is expected to reach USD 16.95 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 11.05 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
6.30% |
2032 Value Projection: |
USD 16.95 Bn |
Figure. Intravenous Solutions Market Share (%), By Region 2025
Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, non-pyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. Dehydration can contribute to various affects such as
- Balance of important minerals (electrolytes) in the body.
- Cognitive (mental) performance.
- Energy level.
- Gastrointestinal function (your ability to digest food and create pee and poop).
- Headache frequency and intensity.
- Physical performance.
- Skin health.
Market Dynamics
Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period. For instance, in July 2022, UNICEF (United Nations International Children's Emergency Fund), an agency of the United Nations responsible for providing humanitarian and developmental aid to children worldwide, published a report which accounted for 9 per cent of all deaths among children under age 5 worldwide in 2020 due to Diarrhoea, whereas over 1,300 young children dying each day, or about 484,000 children a year globally due to diarrhoea.
Moreover, according to an article published in the Lancet Infectious Diseases, September 2018, diarrhoea was the third leading cause of disability-adjusted life year (DALYs) in 2016, which accounted for 74.4 million DALYs, globally. According to the same source, diarrhoea was the eighth leading cause of death, which accounted for 1,655,944 deaths in 2016 globally.
Key features of the study:
- This report provides an in-depth analysis of the global intravenous solutions market, market size (US$ Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2025 - 2032, considering 2024 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global intravenous solutions market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include, Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited, Pfizer, Inc, Otsuka Pharmaceutical Co., Ltd, Ajinomoto Co., Inc., B. Braun Melsungen AG, Soxa Formulations & Research Pvt.Ltd, Sichuan Kelun Pharmaceutical Co Ltd.
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global intravenous solutions market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global intravenous solutions market.
Detailed Segmentation:
- Global Intravenous Solutions Market, By Solution type:
- Saline
- Normal Saline (0.9% NaCl)
- Hypertonic Saline
- Dextran
- Lactated Ringer's
- Amino Acid
- Vitamins & Minerals
- Heparin and Trace Elements
- Mixed Solutions
- Global Intravenous Solutions Market, By Bag type:
- Large Volume Bags (greater than 250ml)
- Small Volume Bags (less than 250ml)
- Global Intravenous Solutions Market, By Application:
- Basic IV Solution
- Nutritional IV Solution
- Blood IV Solution
- Drug IV Solution
- Irrigation IV Solution
- Global Intravenous Solutions Market, By End User:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Home Care Settings
- Global Intravenous Solutions Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Baxter International Inc.
- ICU Medical, Inc.
- Braun Melsungen Ag
- Grifols, S.A.
- Fresenius Kabi USA, LLC
- Vifor Pharma Management Ltd.
- JW Life Science
- Amanta Healthcare
- Axa Parenterals Ltd.
- Salius Pharma Private Limited.
- Pfizer, Inc.
- Otsuka Pharmaceutical Co., Ltd
- Ajinomoto Co., Inc.
- Braun Melsungen AG
- Soxa Formulations & Research Pvt.Ltd
- Sichuan Kelun Pharmaceutical Co Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Solution
- Market Snapshot, By Bag Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Epidemiology
- Porter's Five Forces Analysis
4. Global Intravenous Solutions Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- COVID-19 Impact on the market
5. Global Intravenous Solutions Market, By Solution, 2020 - 2032, (US$ Billion)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Saline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Normal Saline (0.9% NaCl)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Hypertonic Saline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Dextran
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Lactated Ringer's
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Amino Acid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Vitamins & Minerals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Heparin and trace elements
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Mixed Solutions
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
6. Global Intravenous Solutions Market, By Bag Type, 2020 - 2032, (US$ Billion)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Large Volume Bags (greater than 250ml)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Small Volume Bags (less than 250ml)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
7. Global Intravenous Solutions Market, By Application, 2020 - 2032, (US$ Billion)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Basic IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Nutritional IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Blood IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Drug IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Irrigation IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
8. Global Intravenous Solutions Market, By End User, 2020 - 2032, (US$ Billion)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Ambulatory Surgery Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Home care Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
9. Global Intravenous Solutions Market, By Region, 2020 - 2032, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Billion)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Heat Map Analysis
- Company Profile
- Baxter International Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Vifor Pharma Management Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Salius Pharma Private Limited.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Otsuka Pharmaceutical Co., Ltd
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Soxa Formulations & Research Pvt. Ltd
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Sichuan Kelun Pharmaceutical Co Ltd
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
11. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. Section
- References
- Research Methodology
- About Us and Sales Contact
관련자료
